首頁 > 市場調查報告書 > 醫療設備

眼科設備

眼內植入市場規模、佔有率和成長分析（按產品、應用、最終用戶和地區分類）—產業預測（2025-2032 年）

市場調查報告書

商品編碼

1865334

眼內植入市場規模、佔有率和成長分析（按產品、應用、最終用戶和地區分類）—產業預測（2025-2032 年）

Ocular Implants Market Size, Share, and Growth Analysis, By Product (Intraocular Lenses (IOLs), Corneal Implants), By Application (Cataract Surgery, Refractive Errors), By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年11月05日 | 出版商:

SkyQuest | 英文 170 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2023 年，全球眼內植入市場規模將達到 153 億美元，到 2024 年將達到 161.7 億美元，到 2032 年將達到 252 億美元，預測期（2025-2032 年）的複合年成長率為 5.7%。

全球人工眼內植入市場正經歷顯著成長，這主要得益於眼科疾病發病率的上升、人口老化的快速發展以及眼科研發領域的大量投資。白內障、青光眼、老齡化黃斑部病變和糖尿病視網膜病變等眼科疾病的增加，主要歸因於不良的生活習慣和長時間接觸電子螢幕。此外，老年人口尤其容易出現視力問題，從而推動了對人工眼內植入的需求。大眾對可預防性失明及其治療方案的認知不斷提高，預計也將促進市場普及。此外，眼科設施和手術技術的進步也為市場銷售提供了支持，但挑戰仍然存在，包括高昂的費用、熟練專業人員短缺、報銷管道有限以及術後併發症的風險。

全球眼內植入市場促進因素

全球眼內植入市場的主要促進因素之一是白內障、青光眼和老齡化黃斑部病變等視力相關疾病的日益普遍。人口老化和生活方式因素導致這些眼科疾病率上升，進而推動了對創新手術治療方案（包括先進的眼內植入）的需求。此外，植入設計和微創手術技術的進步正在改善患者的治療效果和安全性，進一步促進了這些設備的應用。隨著醫療機構致力於改善視力保健，不斷變化的患者需求和醫療創新預計將顯著推動眼內植入市場的成長。

限制全球眼內植入市場的因素

全球眼內植入市場的主要限制因素之一是先進的眼內植入手術和器械的高昂費用。這種經濟負擔可能會阻礙患者接受必要的治療，尤其是在醫療預算有限、保險覆蓋不足的新興經濟體。此外，植入手術的複雜性會導致恢復時間延長和併發症風險增加，進一步降低潛在患者的治療意願。監管壁壘和冗長的新產品核准流程也會阻礙創新並增加成本，可能限制市場成長，並影響有需要的患者獲得尖端眼科解決方案的機會。

全球眼內植入市場趨勢

全球眼內植入市場正呈現出智慧技術和藥物釋放型技術融合的顯著趨勢。各公司正加大研發投入，致力於開發先進的眼內植入，以實現對青光眼、老齡化黃斑部病變等慢性眼科疾病患者的持續藥物輸送和即時監測。奈米技術、無線通訊和微流體系統等創新解決方案的引入，凸顯了眼內植入領域的發展趨勢。這項變革不僅有望提升治療效果，也有助於提高患者依從性，最終推動市場成長，並重塑眼科護理管理的未來。

Alcon Inc.
Johnson & Johnson Vision（Johnson & Johnson）
Bausch+Lomb Inc.
Carl Zeiss AG
STAAR Surgical Company
Hoya Corporation（Surgical Optics division）
Glaukos Corporation
Novartis AG（Ophthalmic implants）
MORCHER GmbH
OSD Medical GmbH
Pfizer Inc.（Ophthalmic device/implants segment）
Ophtec BV
Rayner Intraocular Lenses Limited
SIFI SpA
Lenstec Inc.
HumanOptics AG
Alcon Laboratories（a Novartis company）（duplicate replaced）
Second Sight Medical Products Inc.
OptiMedica Corporation（implants segment）
Envision Surgical Technologies Inc.

結論與建議

簡介目錄

Product Code: SQMIG35B2264

Global Ocular Implants Market size was valued at USD 15.3 billion in 2023 and is poised to grow from USD 16.17 billion in 2024 to USD 25.2 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global ocular implants market is experiencing significant growth driven by the increasing prevalence of ocular diseases, a rapidly expanding elderly population, and substantial investments in ophthalmic research and development. The rise in eye disorders, particularly cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy, is largely attributed to poor lifestyle choices and heightened digital screen exposure. Furthermore, the aging demographic is particularly susceptible to vision-related issues, reinforcing the demand for ocular implants. Enhanced public awareness regarding preventable blindness and available treatment options is also expected to drive market adoption. Additionally, advancements in ophthalmology facilities and surgical capabilities are supporting market sales, despite challenges such as high costs, a shortage of skilled professionals, limited reimbursement options, and potential post-surgery complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ocular Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ocular Implants Market Segments Analysis

Global Ocular Implants Market is segmented by Product, Application, End-User and region. Based on Product, the market is segmented into Intraocular Lenses (IOLs), Corneal Implants, Glaucoma Implants (e.g., shunts, valves), Retinal Implants, Orbital Implants and Other Ocular Implants. Based on Application, the market is segmented into Cataract Surgery, Refractive Errors, Glaucoma Treatment, Retinal Disorders (e.g., AMD, RP), Corneal Diseases and Orbital Trauma / Reconstruction. Based on End-User, the market is segmented into Hospitals & Clinics, Ophthalmic Surgery Centres and Ambulatory Surgical Centres (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ocular Implants Market

One of the primary market drivers for the global ocular implants market is the rising prevalence of vision-related disorders, such as cataracts, glaucoma, and age-related macular degeneration. This increase in ocular conditions, driven by an aging population and lifestyle factors, is propelling the demand for innovative surgical solutions, including advanced ocular implants. Additionally, technological advancements in implant design and minimally invasive surgical techniques are enhancing patient outcomes and safety, further boosting the adoption of these devices. As healthcare providers focus on improving vision care, the ocular implants market is poised for significant growth driven by these evolving patient needs and medical innovations.

Restraints in the Global Ocular Implants Market

One significant market restraint for the global ocular implants market is the high cost associated with advanced ocular implant procedures and devices. The financial burden can deter patients from seeking necessary treatments, particularly in emerging economies where healthcare budgets are limited and insurance coverage may be inadequate. Additionally, the complex surgical nature of implant procedures can lead to prolonged recovery times and potential complications, further discouraging potential patients. Regulatory hurdles and lengthy approval processes for new products can also stifle innovation and increase costs, limiting market growth and accessibility to state-of-the-art ocular solutions for those in need.

Market Trends of the Global Ocular Implants Market

The Global Ocular Implants market is witnessing a significant trend towards the integration of smart and drug-eluting technologies. Companies are increasingly focusing on research and development to create advanced ocular implants that facilitate sustained drug delivery and real-time monitoring, catering particularly to patients with chronic eye conditions such as glaucoma and macular degeneration. The adoption of innovative solutions, including nanotechnology, wireless communication, and microfluidic systems, underscores the evolving landscape of ocular implants. This shift not only enhances treatment efficacy but also improves patient compliance, ultimately driving growth and reshaping the future of ocular health management.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Assessment
Regulatory Landscape
Customer & Buying Criteria Analysis

Global Ocular Implants Market Size by Product & CAGR (2025-2032)

Market Overview
Intraocular Lenses (IOLs)
Corneal Implants
Glaucoma Implants (e.g., shunts, valves)
Retinal Implants
Orbital Implants
Other Ocular Implants

Global Ocular Implants Market Size by Application & CAGR (2025-2032)

Market Overview
Cataract Surgery
Refractive Errors
Glaucoma Treatment
Retinal Disorders (e.g., AMD, RP)
Corneal Diseases
Orbital Trauma / Reconstruction

Global Ocular Implants Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals & Clinics
Ophthalmic Surgery Centres
Ambulatory Surgical Centres (ASCs)

Global Ocular Implants Market Size & CAGR (2025-2032)

North America (Product, Application, End-User)
- US
- Canada
Europe (Product, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Alcon Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Vision (Johnson & Johnson)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch + Lomb Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STAAR Surgical Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoya Corporation (Surgical Optics division)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glaukos Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Ophthalmic implants)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MORCHER GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OSD Medical GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (Ophthalmic device/implants segment)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ophtec BV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rayner Intraocular Lenses Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SIFI S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lenstec Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HumanOptics AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Laboratories (a Novartis company) (duplicate replaced)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Second Sight Medical Products Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OptiMedica Corporation (implants segment)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Envision Surgical Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments